Insights

Differentiated Monitoring ViTrack provides continuous cuffless blood pressure with beat to beat accuracy and wellness data such as heart rate, rhythm, and respiration in a wearable form factor. This unique capability supports early intervention in hospital, emergency, and remote monitoring contexts, offering potential to replace invasive or occlusive cuffs. Target buyers include health systems, outpatient clinics, rehabilitation centers, and partnerships with device manufacturers or telehealth providers for OEM or white label arrangements.

Partnership Opportunities NSF funding validates the technology and creates collaboration opportunities with academia and government programs. Use this credibility to pursue joint research with academic medical centers, sponsored trials, and pilot programs. Engage these efforts to accelerate validation, generate clinical data, and open procurement channels through research partnerships.

Growth and Agility Dynocardia is a small agile company with growth potential and openness to flexible commercial models. Consider pilots and staged deployments with tiered pricing, licensing, and white label or OEM arrangements to fit budgets of mid sized hospitals and specialty clinics. Build distribution through partners serving digital health, telemedicine, and home care markets.

Interoperability Focus ViTrack data rich platform supports interoperability with hospital information systems, electronic health records, and remote monitoring ecosystems. Emphasize secure data integration, APIs, and regulatory compliance in discussions. Their current technology stack indicates lightweight operations and potential for rapid go to market with cloud based workflows.

Competitive Positioning Competitive landscape includes large players yet ViTrack can win by offering cuffless wearable noninvasive continuous BP and concise data sets. Focus on segments underserved by big incumbents such as perioperative monitoring, remote patient management, and early warning systems. Build credibility with clinical validation and pilots to shorten procurement cycles in hospitals and research institutions.

Dynocardia, Inc. Tech Stack

Dynocardia, Inc. uses 4 technology products and services including Squarespace, NSONE, Google Workspace, and more. Explore Dynocardia, Inc.'s tech stack below.

  • Squarespace
    Content Management System
  • NSONE
    Domain Name Services
  • Google Workspace
    Email
  • Google Fonts API
    Font Scripts

Dynocardia, Inc.'s Email Address Formats

Dynocardia, Inc. uses at least 1 format(s):
Dynocardia, Inc. Email FormatsExamplePercentage
FirstL@dynocardia.careJohnD@dynocardia.care
100%

Frequently Asked Questions

Where is Dynocardia, Inc.'s headquarters located?

Minus sign iconPlus sign icon
Dynocardia, Inc.'s main headquarters is located at Cambridge, Massachusetts 02142 United States. The company has employees across 2 continents, including North AmericaAsia.

What is Dynocardia, Inc.'s official website and social media links?

Minus sign iconPlus sign icon
Dynocardia, Inc.'s official website is dynocardia.care and has social profiles on LinkedInCrunchbase.

What is Dynocardia, Inc.'s NAICS code?

Minus sign iconPlus sign icon
Dynocardia, Inc.'s NAICS code is 3391 - Medical Equipment and Supplies Manufacturing.

How many employees does Dynocardia, Inc. have currently?

Minus sign iconPlus sign icon
As of June 2026, Dynocardia, Inc. has approximately 16 employees across 2 continents, including North AmericaAsia. Key team members include Ceo, President, And Co-Founder: M. T.Chief Product Officer: J. W.Vice President, Market And Business Development: M. S.. Explore Dynocardia, Inc.'s employee directory with LeadIQ.

What industry does Dynocardia, Inc. belong to?

Minus sign iconPlus sign icon
Dynocardia, Inc. operates in the Medical Equipment Manufacturing industry.

What technology does Dynocardia, Inc. use?

Minus sign iconPlus sign icon
Dynocardia, Inc.'s tech stack includes SquarespaceNSONEGoogle WorkspaceGoogle Fonts API.

What is Dynocardia, Inc.'s email format?

Minus sign iconPlus sign icon
Dynocardia, Inc.'s email format typically follows the pattern of FirstL@dynocardia.care. Find more Dynocardia, Inc. email formats with LeadIQ.

How much funding has Dynocardia, Inc. raised to date?

Minus sign iconPlus sign icon
As of June 2026, Dynocardia, Inc. has raised $675K in funding. The last funding round occurred on Mar 14, 2025 for $675K.

When was Dynocardia, Inc. founded?

Minus sign iconPlus sign icon
Dynocardia, Inc. was founded in 2018.
Dynocardia, Inc. logo

Dynocardia, Inc.

Medical Equipment ManufacturingMassachusetts, United States11-50 Employees

Dynocardia, Inc. is a medical equipment manufacturer based in Cambridge, Massachusetts, focused on biomedical device development aimed at addressing unmet healthcare needs. Its lead device, ViTrack, records blood pressure continuously in a cuff-less, wrist-worn form, providing beat-to-beat measurements with data on heart rate, heart rhythm, and respiration, enabling early intervention for potential acute events. The company positions itself in the medical device sector by delivering non-invasive monitoring capabilities that compare in immediacy and detail to invasive arterial lines, while offering mobility and ease of use for ongoing physiological assessment.

Dynocardia targets healthcare providers and systems seeking continuous, non-invasive monitoring solutions that can enhance patient management outside of traditional occlusive systems. The development work is centered around wearable technology for accurate, continuous vital signs monitoring, with the potential to inform timely clinical decisions. The organization operates from Cambridge, within the medical equipment landscape, and maintains a focus on translating its innovations into practical, bedside applications.

Section iconCompany Overview

Headquarters
Cambridge, Massachusetts 02142 United States
NAICS Code
3391 - Medical Equipment and Supplies Manufacturing
Founded
2018
Employees
11-50

Section iconFunding & Financials

  • $675K

    Dynocardia, Inc. has raised a total of $675K of funding over 10 rounds. Their latest funding round was raised on Mar 14, 2025 in the amount of $675K.

  • $1M$10M

    Dynocardia, Inc.'s revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $675K

    Dynocardia, Inc. has raised a total of $675K of funding over 10 rounds. Their latest funding round was raised on Mar 14, 2025 in the amount of $675K.

  • $1M$10M

    Dynocardia, Inc.'s revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.